TrueMark Investments’s Aimei Health Technology Co Right AFJKR Stock Holding History

TrueMark Investments’s Portfolio AFJKR Stock Details AFJKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.62K	Hold	14,391	–	–	﹤0.01%	157
2025 Q4	$5.76K	Hold	14,391	–	–	﹤0.01%	229
2025 Q3	$4.32K	Buy	+14,391	New	+$5.18K	﹤0.01%	184
2025 Q2	–	Sell	-14,391	Closed	-$4.46K	–	142
2025 Q1	$4.46K	Hold	14,391	–	–	﹤0.01%	189
2024 Q4	$2.3K	Hold	14,391	–	–	﹤0.01%	169
2024 Q3	$3.81K	Hold	14,391	–	–	﹤0.01%	226
2024 Q2	$3.18K	Hold	14,391	–	–	﹤0.01%	206
2024 Q1	$2.82K	Buy	+14,391	New	+$2.85K	﹤0.01%	80

Other funds holding AFJKR

HCI

Harraden Circle Investments New York $499M AUM 24.03% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

TrueMark Investments's AFJKR Position: Q1 2026 in Review

TrueMark Investments held its Aimei Health Technology Co Right (AFJKR) position steady in Q1 2026 at 14,391 shares worth $4.62K. The position accounts for ﹤0.01% of the portfolio, ranked #157.

TrueMark Investments first reported a position in AFJKR in Q1 2024 and has held it in 8 quarters since. The position peaked at $5.76K in Q4 2025. 15 funds tracked by Wall St. Rank hold AFJKR as of Q1 2026.

TrueMark Investments held 14,391 shares of Aimei Health Technology Co Right worth $4.62K as of Q1 2026.
TrueMark Investments left its Aimei Health Technology Co Right share count unchanged in Q1 2026.
Aimei Health Technology Co Right made up ﹤0.01% of TrueMark Investments's portfolio in Q1 2026, its #157 holding.
TrueMark Investments first reported a position in Aimei Health Technology Co Right in Q1 2024 and has held it in 8 quarters since.
TrueMark Investments's Aimei Health Technology Co Right position peaked at $5.76K in Q4 2025.
15 funds tracked by Wall St. Rank held Aimei Health Technology Co Right as of Q1 2026.

Based on TrueMark Investments's 13F filing for Q1 2026, filed 20 Apr 2026.